RSS

Bial

An exclusive licence agreement has been announced for the importation, packaging and commercialisation of Opicapone — a new treatment for Parkinson’s disease — in China (excluding Hong Kong, Macao and Taiwan). more

News

The European Medicines Agency (EMA) has approved Zebinix (eslicarbazepine acetate) for use as once-daily monotherapy to treat adults with newly-diagnosed partial-onset epilepsy. more

News

Information has surfaced that suggests the drug, which caused the death of one person and the hospitalisation of five others, killed five dogs during a pre-clinical test more

News